SUBJECTS : Oncology | Cancer Screening | Cancer Prevention | Epidemiology | Public Healt
JNCI Cancer Spectrum: 2023, vol: , issue:
- 1)- David S Black, Matthew G Kirkpatrick. Effect of a mindfulness training app on a cigarette quit attempt: an investigator-blinded, 58-county randomized controlled trial. JNCI cancer spectrum. 2023, 7 (6):
Cited : 0Read More - 2)- Zhengyi Deng, Miranda R Jones, Antonio C Wolff, Kala Visvanathan. Evaluation of Predict, a prognostic risk tool, after diagnosis of a second breast cancer. JNCI cancer spectrum. 2023, 7 (6): Cited : 0Read More
- 3)- Rossybelle Amorrortu, Melany Garcia, Yayi Zhao, Issam El Naqa, Yoganand Balagurunathan, Dung-Tsa Chen, Thanh Thieu, Matthew B Schabath, Dana E Rollison. Overview of approaches to estimate real-world disease progression in lung cancer. JNCI cancer spectrum. 2023, 7 (6): Cited : 0Read More
- 4)- Alexandra Hudson, Marcia Fournier, James Coulombe, Danielle Daee. Using existing pediatric cancer data from the Gabriella Miller Kids First Data Resource Program. JNCI cancer spectrum. 2023, 7 (6): Cited : 2Read More
- 5)- Kristine G Reed, Zhaojun Sun, Jonathan G Yabes, Coleman Drake, Nicole Ober, Bruce Jacobs, G J van Londen, Cathy J Bradley, Lindsay M Sabik. Assessing characteristics of populations seen at Commission on Cancer facilities using Pennsylvania linked data. JNCI cancer spectrum. 2023, 7 (6): Cited : 2Read More
- 6)- Chris Parker, Nina Tunariu, Holly Tovey, Roberto Alonzi, Matthew D Blackledge, Gary J R Cook, Sue Chua, Yong Du, Shaista Hafeez, Iain Murray, Anwar R Padhani, John Staffurth, Alison Tree, Helen Stidwill, Jessica Finch, Andra Curcean, Peter Chatfield, Sophie Perry, Dow-Mu Koh, Emma Hall. Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response. JNCI cancer spectrum. 2023, 7 (6): Cited : 2Read More
- 7)- Alec Zhu, Stephen Rhodes, Weichuan Dong, Johnie Rose, Jennifer Cullen, David B Miller, Daniel E Spratt, Lee Ponsky, Daniel Shoag, Erika Trapl, Fredrick Schumacher, Suhas Penukonda, Aaron Brant, Mary O Strasser, Siran M Koroukian, Sarah Markt, Jonathan E Shoag. Individual-level home values and cancer mortality in a statewide registry. JNCI cancer spectrum. 2023, 7 (6): Cited : 1Read More
- 8)- Dejan K Filipas, Edoardo Beatrici, Jose I Nolazco, Zhiyu Qian, Phillip Marks, Muhieddine Labban, Benjamin V Stone, Phillip M Pierorazio, Stuart R Lipsitz, Quoc-Dien Trinh, Steven L Chang, Alexander P Cole. The national utilization of nonoperative management for small renal masses over 10 years. JNCI cancer spectrum. 2023, 7 (6): Cited : 0Read More
- 9)- Elnaz Naderi, Miguel E Aguado-Barrera, Line M H Schack, Leila Dorling, Tim Rattay, Laura Fachal, Holly Summersgill, Laura Martínez-Calvo, Ceilidh Welsh, Tom Dudding, Yasmin Odding, Ana Varela-Pazos, Rajesh Jena, David J Thomson, Roel J H M Steenbakkers, Joe Dennis, Ramón Lobato-Busto, Jan Alsner, Andy Ness, Chris Nutting, Antonio Gómez-Caamaño, Jesper G Eriksen, Steve J Thomas, Amy M Bates, Adam J Webb, Ananya Choudhury, Barry S Rosenstein, Begona Taboada-Valladares, Carsten Herskind, David Azri. Large-scale meta-genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types. JNCI cancer spectrum. 2023, 7 (6): Cited : 0Read More
- 10)- Wynne E Norton, Gila Neta, Paul B Jacobsen. National Cancer Institute funding for rapid cycle interventional research in cancer care delivery. JNCI cancer spectrum. 2023, 7 (6): Cited : 0Read More
- 11)- Niki Oveisi, Vicki Cheng, Lori A Brotto, Stuart Peacock, Helen McTaggart-Cowan, Gillian Hanley, Sharlene Gill, Meera Rayar, Amirrtha Srikanthan, Ursula Ellis, Mary A De Vera. Sexual health outcomes among adolescent and young adult cancer patients: a systematic review and meta-analysis. JNCI cancer spectrum. 2023, 7 (6): Cited : 1Read More
- 12)- Ashley Wilder Smith, Lisa DiMartino, Sofia F Garcia, Sandra A Mitchell, Kathryn J Ruddy, Justin D Smith, Sandra L Wong, September Cahue, David Cella, Roxanne E Jensen, Michael J Hassett, Christine Hodgdon, Barbara Kroner, Raymond U Osarogiagbon, Jennifer Popovic, Kimberly Richardson, Deborah Schrag, Andrea L Cheville, . Systematic symptom management in the IMPACT Consortium: rationale and design for 3 effectiveness-implementation trials. JNCI cancer spectrum. 2023, 7 (6): Cited : 5Read More
- 13)- Jia-Yi Qian, Lei-Lei Wu, Li-Yan Zhang, Kun Li, Zhi-Xin Li, Yong Zhao, Dong Xie. Prognostic evaluation of stage I lung adenocarcinoma based on systematic inflammatory response. JNCI cancer spectrum. 2023, 7 (6): Cited : 0Read More
- 14)- Andrew Harper, Nicole Maseja, Reilly Parkinson, Mohammadreza Pakseresht, Sarah McKillop, Jan-Willem Henning, Linda Watson, Colleen Cuthbert, Winson Cheung, Miranda M Fidler-Benaoudia. Symptom severity and trajectories among adolescent and young adult patients with cancer. JNCI cancer spectrum. 2023, 7 (6): Cited : 3Read More
- 15)- Amit K Garg, Mike Hernandez, Pamela J Schlembach, John R Bowers, Mary F McAleer, Paul D Brown, Ramesh Gopal, Lee Wiederhold, Todd Swanson, Shalin J Shah, Jing Li, Sherise D Ferguson, Nancy V Philip, Lilybeth DeGracia, Elizabeth S Bloom, Stephen G Chun. A phase II clinical trial of frameless, fractionated stereotactic radiation therapy for brain metastases. JNCI cancer spectrum. 2023, 7 (6): Cited : 0Read More
- 16)- Oliver Sartor. Radium-223 and bone metastatic disease: still more to learn. JNCI cancer spectrum. 2023, 7 (6): Cited : 0Read More
- 17)- Michaela A Dinan, Stephanie B Wheeler. Zillow MD: Do housing prices predict cancer survival? JNCI cancer spectrum. 2023, 7 (6): Cited : 0Read More
- 18)- Sharon H Nahm, Andrew J Martin, Josephine M Clayton, Peter Grimison, Erin B Moth, Nick Pavlakis, Katrin Sjoquist, Megan E S Smith-Uffen, Annette Tognela, Anuradha Vasista, Martin R Stockler, Belinda E Kiely. Accuracy of oncologists' estimates of expected survival time in advanced cancer. JNCI cancer spectrum. 2023, 7 (6): Cited : 0Read More
- 19)- Gustav Stålhammar. Comprehensive causes of death in uveal melanoma: mortality in 1530 consecutively diagnosed patients followed until death. JNCI cancer spectrum. 2023, 7 (6): Cited : 3Read More
- 20)- Nikita V Baclig, Warren Scott Comulada, Patricia A Ganz. Mental health and care utilization in survivors of adolescent and young adult cancer. JNCI cancer spectrum. 2023, 7 (6): Cited : 2Read More
- 21)- Senna W M Lammers, Sandra M E Geurts, Irene E G van Hellemond, Astrid C P Swinkels, Carolien H Smorenburg, Maurice J C van der Sangen, Judith R Kroep, Hiltje de Graaf, Aafke H Honkoop, Frans L G Erdkamp, Wilfred K de Roos, Sabine C Linn, Alexander L T Imholz, Marjolein L Smidt, Ingeborg J H Vriens, Vivianne C G Tjan-Heijnen. The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer. JNCI cancer spectrum. 2023, 7 (6): Cited : 3Read More
- 22)- Leticia M Nogueira. The climate and nature crisis: implications for cancer control. JNCI cancer spectrum. 2023, 7 (6): Cited : 0Read More
- 23)- Jared C Foster, Edward L Korn, Boris Freidlin, Jeffrey A Moscow. The potential to backfill in phase I trials: the National Cancer Institute's Cancer Therapy Evaluation Program experience. JNCI cancer spectrum. 2023, 7 (6): Cited : 1Read More
- 24)- Kei Kawana, Osamu Kobayashi, Yuji Ikeda, Hideaki Yahata, Takashi Iwata, Toyomi Satoh, Azusa Akiyama, Daichi Maeda, Yumiko Hori-Hirose, Yukari Uemura, Kaori Nakayama-Hosoya, Kanoko Katoh, Yuki Katoh, Takahiro Nakajima, Ayumi Taguchi, Atsushi Komatsu, Mikiko Asai-Sato, Naoko Tomita, Kiyoko Kato, Daisuke Aoki, Shizunobu Igimi, Ai Kawana-Tachikawa, Danny J Schust. Phase I and II randomized clinical trial of an oral therapeutic vaccine targeting human papillomavirus for treatment of cervical intraepithelial neoplasia 2 and 3. JNCI cancer spectrum. 2023, 7 (6): Cited : 5Read More
- 25)- Jawad Alrawabdeh, Marah Alzu'bi, Muntaser Alzyoud, Nada Odeh, Yazan Hamadneh, Hira Mian, Ghulam Rehman Mohyuddin, Amar H Kelkar, Aaron M Goodman, Rajshekhar Chakraborty, David A Russler-Germain, Nikita Mehra, Diva Baggio, Edward R Scheffer Cliff, Samer Al Hadidi. Characteristics of post hoc subgroup analyses of oncology clinical trials: a systematic review. JNCI cancer spectrum. 2023, 7 (6): Cited : 0Read More
- 26)- Matthew T Warkentin, Yibing Ruan, Larry F Ellison, Jean-Michel Billette, Alain A Demers, Fei-Fei Liu, Darren R Brenner. Progress in cancer control leads to a substantial number of cancer deaths avoided in Canada. JNCI cancer spectrum. 2023, 7 (6): Cited : 0Read More
- 27)- Ghazal Khajir, Benjamin Press, Soum Lokeshwar, Kamyar Ghabili, Syed Rahman, Mursal Gardezi, Samuel Washington, Matthew R Cooperberg, Preston Sprenkle, Michael S Leapman. Prostate cancer risk stratification using magnetic resonance imaging-ultrasound fusion vs systematic prostate biopsy. JNCI cancer spectrum. 2023, 7 (6): Cited : 0Read More
- 28)- Chinenye Lynette Ejezie, Lara S Savas, Casey Durand, Ross Shegog, Paula Cuccaro. The prevalence of human papillomavirus vaccination among racial and ethnic minority adolescents during the COVID-19 pandemic. JNCI cancer spectrum. 2023, 7 (5): Cited : 2Read More
- 29)- Partha Pratim Ray. RE: Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift. JNCI cancer spectrum. 2023, 7 (5): Cited : 1Read More
- 30)- Sumi Sinha, A Jay Holmgren, Julian C Hong, Lisa S Rotenstein. Ctrl-C: a cross-sectional study of the electronic health record usage patterns of US oncology clinicians. JNCI cancer spectrum. 2023, 7 (5): Cited : 0Read More
- 31)- Monalisa Chandra, Ikponmwosa Osaghae, Rajesh Talluri, Sanjay Shete. Barriers to human papillomavirus vaccine uptake: role of state religiosity and healthcare professionals' participation in a state vaccine program. JNCI cancer spectrum. 2023, 7 (5): Cited : 0Read More
- 32)- Jenny S Guadamuz, Xiaoliang Wang, Cleo A Ryals, Rebecca A Miksad, Jeremy Snider, James Walters, Gregory S Calip. Socioeconomic status and inequities in treatment initiation and survival among patients with cancer, 2011-2022. JNCI cancer spectrum. 2023, 7 (5): Cited : 6Read More
- 33)- Julie A Barta, Cherie P Erkmen, Christine S Shusted, Ronald E Myers, Chelsea Saia, Sarah Cohen, Jocelyn Wainwright, Charnita Zeigler-Johnson, Farouk Dako, Richard Wender, Gregory C Kane, Anil Vachani, Katharine A Rendle. The Philadelphia Lung Cancer Learning Community: a multi-health-system, citywide approach to lung cancer screening. JNCI cancer spectrum. 2023, 7 (5): Cited : 6Read More
- 34)- Tina W F Yen, I-Wen Pan, Ya-Chen Tina Shih. Impact of state telehealth policies on telehealth use among patients with newly diagnosed cancer. JNCI cancer spectrum. 2023, 7 (5): Cited : 2Read More
- 35)- Aubrey Villalobos, David A Chambers. Advancing the science of integrating multiple interventions by blending and bundling. JNCI cancer spectrum. 2023, 7 (5): Cited : 2Read More
- 36)- Xu Ji, Kewei Sylvia Shi, Kathryn J Ruddy, Jingxuan Zhao, Ann C Mertens, K Robin Yabroff, Sharon M Castellino, Xuesong Han. Medicaid expansion is associated with treatment receipt, timeliness, and outcomes among young adults with breast cancer. JNCI cancer spectrum. 2023, 7 (5): Cited : 1Read More
- 37)- Dawson Hill, Samuel R Kaufman, Mary K Oerline, Kassem Faraj, Megan E V Caram, Vahakn B Shahinian, Brent K Hollenbeck, Avinash Maganty. In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancer. JNCI cancer spectrum. 2023, 7 (5): Cited : 0Read More
- 38)- Yukio Suzuki, Susu Zhou, Yukihide Ota, Matthew Harrington, Etsuko Miyagi, Hisato Takagi, Toshiki Kuno, Jason D Wright. Toxicity profiles of antibody-drug conjugates for anticancer treatment: a systematic review and meta-analysis. JNCI cancer spectrum. 2023, 7 (5): Cited : 5Read More
- 39)- Aziz Zaanan, Julie Henriques, Anthony Turpin, Sylvain Manfredi, Romain Coriat, Eric Terrebonne, Jean-Louis Legoux, Thomas Walter, Christophe Locher, Olivier Dubreuil, Simon Pernot, Chloé Vernet, Olivier Bouché, Vincent Hautefeuille, Johan Gagniere, Thierry Lecomte, David Tougeron, Thomas Grainville, Dewi Vernerey, Pauline Afchain, Thomas Aparicio. Adjuvant chemotherapy benefit according to T and N stage in small bowel adenocarcinoma: a large retrospective multicenter study. JNCI cancer spectrum. 2023, 7 (5): Cited : 2Read More
- 40)- K Robin Yabroff, Amanda L Boehm, Leticia M Nogueira, Mark Sherman, Cathy J Bradley, Ya-Chen Tina Shih, Nancy L Keating, Scarlett L Gomez, Matthew P Banegas, Stefan Ambs, Dawn L Hershman, James B Yu, Nadeem Riaz, Martin R Stockler, Ronald C Chen, Eduardo L Franco. An essential goal within reach: attaining diversity, equity, and inclusion for the Journal of the National Cancer Institute journals. JNCI cancer spectrum. 2023, 7 (5): Cited : 0Read More
- 41)- Matthew F Hudson, Alicia M Oostdyk, Virginia M Simmons, Julie C Martin. Considering context in area-level socioeconomic status, cancer treatment initiation, and survival. JNCI cancer spectrum. 2023, 7 (5): Cited : 0Read More
- 42)- Daniel R Dickstein, Eric Chen, Nicholas G Zaorsky, Karen Hoffman, Paul Nguyen. Do ask, do tell: improving health outcomes for sexual and gender minorities with cancer. JNCI cancer spectrum. 2023, 7 (5): Cited : 3Read More
- 43)- Harshabad Singh, Ashley Kang, Lisa Bloudek, Ling-I Hsu, Maria Corinna Palanca-Wessels, Michael Stecher, Muriel Siadak, Kimmie Ng. Systematic Literature Review and Meta-Analysis of HER2 Amplification, Overexpression, and Positivity in Colorectal Cancer. JNCI cancer spectrum. 2023, : Cited : 4Read More
- 44)- Jennifer L Moss, Juliette Entenman, Kelsey Stoltzfus, Jiangang Liao, Tracy Onega, Paul L Reiter, Lisa M Klesges, George Garrow, Mack T Ruffin. Self-sampling tools to increase cancer screening among underserved patients: A pilot randomized controlled trial. JNCI cancer spectrum. 2023, : Cited : 0Read More
- 45)- M Diana van Die, Kerry M Bone, Kala Visvanathan, Cecile Kyrø, Dagfinn Aune, Carolyn Ee, Channing J Paller. Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies. JNCI cancer spectrum. 2023, : Cited : 2Read More
- 46)- Marina Elena Cazzaniga, Foluso Ademuyiwa, Thierry Petit, Joke Tio, Daniele Generali, Eva M Ciruelos, Nadia Califaretti, Brigitte Poirier, Antonio Ardizzoia, Arnd Hoenig, Benno Lex, Marie-Ange Mouret-Reynier, Dagmar Giesecke, Nicolas Isambert, Ricardo Masetti, Lacey Pitre, Denise Wrobel, Paule Augereau, Manuela Milani, Sara Rask, Christine Solbach, Laura Pritzker, Sanaa Noubir, Amadeo Parissenti, Maureen Trudeau. Low RNA disruption during neoadjuvant chemotherapy predicts pCR absence in patients with breast cancer. JNCI cancer spectrum. 2023, : Cited : 0Read More
- 47)- Chelsea Anderson, Christopher D Baggett, Stephanie M Engel, Darios Getahun, Nancy T Cannizzaro, Sara Mitra, Clare Meernik, Lisa M Moy, Cecile A Laurent, Xi Zhou, Lanfang Xu, Marilyn L Kwan, William A Wood, Barbara Luke, Chun R Chao, Lawrence H Kushi, Hazel B Nichols. Risk of adverse birth outcomes after adolescent and young adult cancer. JNCI cancer spectrum. 2023, : Cited : 1Read More
- 48)- Claire C Conley, Heather Derry-Vick, Jaeil Ahn, Yi Xia, Li Lin, Kristi D Graves, Wei Pan, Jane M Fall-Dickson, Bryce B Reeve, Arnold L Potosky. Relationship Between Area-Level Socioeconomic Status and Health-Related Quality of Life among Cancer Survivors. JNCI cancer spectrum. 2023, : Cited : 1Read More
- 49)- Eden R Brauer, Laura Petersen, Patricia A Ganz. Survivorship Care in Breast Cancer: Understanding Implementation Barriers through the Lens of the Theoretical Domains Framework. JNCI cancer spectrum. 2023, : Cited : 0Read More
